Page last updated: 2024-08-21

chromonar and arachidonic acid

chromonar has been researched along with arachidonic acid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Costantini, V; Goracci, G; Nenci, GG; Pistolesi, R; Porcellati, S; Prosdocimi, M; Stasi, M1
Dal Bo Zanon, R; Fabris, F; Girolami, A; Luzzatto, G1
Costantini, V; Goracci, G; Nenci, GG; Pistolesi, R; Porcellati, S; Porrovecchio, P; Prosdocimi, M1
Förster, W; Heinroth, I1
Goracci, G; Gresele, P; Nenci, GG; Pieretti, G; Porcellati, S; Prosdocimi, M; Quero, E; Stasi, M1
Goracci, G; Gresele, P; Mezzasoma, AM; Nenci, GG; Prosdocimi, M; Quero, E; Ribaldi, E; Stasi, M1

Other Studies

6 other study(ies) available for chromonar and arachidonic acid

ArticleYear
The coumarin derivative AD6 inhibits the release of arachidonic acid by interfering with phospholipase A2 activity in human platelets stimulated with thrombin.
    Agents and actions, 1990, Volume: 29, Issue:3-4

    Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Chromonar; Coumarins; Diglycerides; Humans; Inositol; Phosphatidylcholines; Phosphatidylinositols; Phospholipases; Phospholipases A; Phospholipases A2; Phospholipids; Plasmalogens; Thrombin

1990
Lack of antiplatelet activity of the new coumarin derivative 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy- carboxylmethoxycoumarin under in vivo conditions in man.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:6

    Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; beta-Thromboglobulin; Blood Platelets; Chromonar; Collagen; Coumarins; Humans; In Vitro Techniques; Platelet Aggregation

1986
AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonyl-meth oxy coumarin) inhibits the release of arachidonic acid in human platelets stimulated by thrombin.
    Thrombosis research, 1987, Jul-01, Volume: 47, Issue:1

    Topics: Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Chromonar; Coumarins; Diglycerides; Dose-Response Relationship, Drug; Humans; Phospholipids; Platelet Aggregation; Radioisotopes; Thrombin; Thromboxane B2

1987
Carbocromen inhibits arachidonic acid-induced platelet aggregation and TXA2 formation.
    Prostaglandins, leukotrienes, and medicine, 1984, Volume: 14, Issue:1

    Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Chromonar; Coumarins; In Vitro Techniques; Platelet Aggregation; Rabbits; Thromboxane A2; Thromboxanes

1984
Cloricromene inhibits G-protein-mediated activation of phospholipase A2 in human platelets.
    Journal of lipid mediators, 1993, Volume: 7, Issue:3

    Topics: Aluminum; Arachidonic Acid; beta-Thromboglobulin; Blood Platelets; Chromonar; Cytosol; Enzyme Activation; Fluorine; GTP-Binding Proteins; Humans; Phosphatidylinositols; Phospholipases A; Phospholipases A2; Thrombin

1993
Cloricromene inhibits leukotriene formation by human polymorphonuclear leucocytes by suppressing arachidonate release from membrane phospholipids.
    Biochemical pharmacology, 1993, Jan-07, Volume: 45, Issue:1

    Topics: Arachidonic Acid; Calcimycin; Chromonar; Dose-Response Relationship, Drug; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Membrane Lipids; Neutrophils; Phospholipids; SRS-A; Zymosan

1993